OBJECTIVES: To compare completion rates of colorectal cancer screening tests within a health maintenance organization before and after widespread adoption of the fecal immunochemical test (FIT). STUDY DESIGN: Retrospective cohort study. METHODS: Using electronic medical records of 113,901 patients eligible for colorectal cancer screening, we examined test completion during 2 successive time periods among those who received an automated screening outreach call. The time periods were: 1) the "guaiac fecal occult blood test (gFOBT) era," a 15-month period during which only gFOBT was routinely offered, and 2) a 9-month "FIT era," when only a new FIT was routinely offered. In addition to analyzing completion rates, we analyzed the impact of practice-level variables and patient-level variables on overall screening completion during the 2 different observation periods. RESULTS: The change from gFOBT to FIT in an integrated care delivery system increased the likelihood of screening completion by 7.7% overall, and the likelihood of screening with a fecal test by 8.9%. The greatest gains in screening completion using FIT were among women and elderly patients. Completion of FIT was not as strongly associated with medical office visits or with having a primary care provider as was screening with gFOBT. CONCLUSIONS: Adoption of FIT within an integrated care system increased completion of colon cancer screening tests within a 9-month assessment period, compared with a previous 15-month gFOBT era. Higher completion rates of the FIT may allow for more effective dissemination of programs to increase colorectal cancer screening through centralized outreach programs.
OBJECTIVES: To compare completion rates of colorectal cancer screening tests within a health maintenance organization before and after widespread adoption of the fecal immunochemical test (FIT). STUDY DESIGN: Retrospective cohort study. METHODS: Using electronic medical records of 113,901 patients eligible for colorectal cancer screening, we examined test completion during 2 successive time periods among those who received an automated screening outreach call. The time periods were: 1) the "guaiac fecal occult blood test (gFOBT) era," a 15-month period during which only gFOBT was routinely offered, and 2) a 9-month "FIT era," when only a new FIT was routinely offered. In addition to analyzing completion rates, we analyzed the impact of practice-level variables and patient-level variables on overall screening completion during the 2 different observation periods. RESULTS: The change from gFOBT to FIT in an integrated care delivery system increased the likelihood of screening completion by 7.7% overall, and the likelihood of screening with a fecal test by 8.9%. The greatest gains in screening completion using FIT were among women and elderly patients. Completion of FIT was not as strongly associated with medical office visits or with having a primary care provider as was screening with gFOBT. CONCLUSIONS: Adoption of FIT within an integrated care system increased completion of colon cancer screening tests within a 9-month assessment period, compared with a previous 15-month gFOBT era. Higher completion rates of the FIT may allow for more effective dissemination of programs to increase colorectal cancer screening through centralized outreach programs.
Authors: Leo S Morales; Jeannette Rogowski; Vicki A Freedman; Steven L Wickstrom; John L Adams; José J Escarce Journal: Prev Med Date: 2004-10 Impact factor: 4.018
Authors: Laura C Seeff; Marion R Nadel; Carrie N Klabunde; Trevor Thompson; Jean A Shapiro; Sally W Vernon; Ralph J Coates Journal: Cancer Date: 2004-05-15 Impact factor: 6.860
Authors: Bernard Levin; David A Lieberman; Beth McFarland; Robert A Smith; Durado Brooks; Kimberly S Andrews; Chiranjeev Dash; Francis M Giardiello; Seth Glick; Theodore R Levin; Perry Pickhardt; Douglas K Rex; Alan Thorson; Sidney J Winawer Journal: CA Cancer J Clin Date: 2008-03-05 Impact factor: 508.702
Authors: Samantha Hendren; Paul Winters; Sharon Humiston; Amna Idris; Shirley X L Li; Patricia Ford; Raymond Specht; Stephen Marcus; Michael Mendoza; Kevin Fiscella Journal: J Gen Intern Med Date: 2013-07-02 Impact factor: 5.128
Authors: Mary E Charlton; Michelle A Mengeling; Thorvardur R Halfdanarson; Nader M Makki; Ashish Malhotra; J Stacey Klutts; Barcey T Levy; Peter J Kaboli Journal: J Rural Health Date: 2013-10-25 Impact factor: 4.333